TCL Archive Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years September 28, 2012
TCL Archive NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC April 30, 2010
TCL Archive FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer October 20, 1995